120 related articles for article (PubMed ID: 1037267)
1. Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).
Takenaka T; Usuda S; Nomura T; Maeno H; Sado T
Arzneimittelforschung; 1976; 26(12):2172-8. PubMed ID: 1037267
[TBL] [Abstract][Full Text] [Related]
2. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients.
Takenaka T; Handa J
Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):1-11. PubMed ID: 33121
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
Nakaya H; Kanno M
Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
Sakamoto N; Terai M; Takenaka T; Maeno H
Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
[No Abstract] [Full Text] [Related]
6. Determination of a new cerebral vasodilator 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93) in plasma by electron capture gas chromatography.
Higuchi S; Sasaki H; Sado T
J Chromatogr; 1975 Jul; 110(2):301-7. PubMed ID: 1150838
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
Vater W; Kroneberg G; Hoffmeister F; Saller H; Meng K; Oberdorf A; Puls W; Schlossmann K; Stoepel K
Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472
[No Abstract] [Full Text] [Related]
8. [The effect of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid methyl ester on myocardial metabolism, hemodynamics, blood gases and general metabolism of man].
Kochsiek K; Neubaur J
Arzneimittelforschung; 1972 Feb; 22(2):353-8. PubMed ID: 5067487
[No Abstract] [Full Text] [Related]
9. Chemical control of cerebral circulation. Modification by a new vasodilator (YC-93).
Oishi M; Niimi T; Takagi S; Takeoka T; Seki T; Toyoda M; Gotoh F
J Neurol Sci; 1978 May; 36(3):403-10. PubMed ID: 681971
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
[TBL] [Abstract][Full Text] [Related]
11. The effect of the nitrophenyl-dimethyl-dihydropyridine derivative nifedipine on intercoronary collateral circulation.
Kanazawa T; Suzuki N; Ino-oka E; Takahashi T; Mori A
Arzneimittelforschung; 1974 Sep; 24(9):1267-74. PubMed ID: 4479789
[No Abstract] [Full Text] [Related]
12. [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].
Kubo K; Karasawa A; Yamada K; Nito M; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 May; 79(5):383-400. PubMed ID: 7129248
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
Satoh K; Yanagisawa T; Taira N
Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
[TBL] [Abstract][Full Text] [Related]
14. Vasodilating effect of flunarizine in anesthetized dogs.
Kato H; Kurihara J; Ishii K; Kasuya Y
Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
[TBL] [Abstract][Full Text] [Related]
15. New 1,4-dihydropyridines with vasoconstrictor action through activation of Ca++-channels.
Takenaka T; Inagaki O; Terai M; Asano M; Kubo K
J Pharmacol Exp Ther; 1988 Feb; 244(2):699-708. PubMed ID: 2450201
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator action of KB-944, a new calcium antagonist.
Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
[TBL] [Abstract][Full Text] [Related]
17. [Effects of flunarizine on cerebral venous outflow and cerebral oxygen consumption].
Kubo K; Jageneau T
Nihon Yakurigaku Zasshi; 1982 Jun; 79(6):529-41. PubMed ID: 7129242
[TBL] [Abstract][Full Text] [Related]
18. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
19. [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].
Grün G; Fleckenstein A
Arzneimittelforschung; 1972 Feb; 22(2):334-44. PubMed ID: 4623697
[No Abstract] [Full Text] [Related]
20. Effects of papaveroline-monosulphate on the systemic and regional circulation in the dog.
Data PG; Rolfo A; Cacchio M; Di Tano G
Farmaco Sci; 1981 Apr; 36(4):302-14. PubMed ID: 7250364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
